Preanalytic parameters in epidermal growth factor receptor mutation testing for non–small cell lung carcinoma: A review of cytologic series

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|123|11|633-643

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.123, Iss.11, 2015-11, pp. : 633-643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

By                    

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 464-474

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I–IV Non-Small Cell Lung Cancer Patients

By  

Respiration, Vol. 85, Iss. 2, 2012-07 ,pp. : 119-125

Karger

Access to resources Recommend Favorite